Journal
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
Volume 226, Issue 2, Pages -Publisher
MOSBY-ELSEVIER
DOI: 10.1016/j.ajog.2021.09.018
Keywords
antibiotics; bacterial vaginosis recurrence; biofilms; molecular bacterial vaginosis; mucosal immunity; vaginal microbiome
Categories
Funding
- Centers for Disease Control and Prevention
- United States Agency for International Development
- CONRAD/Eastern Virginia Medical School [GPO-A-00-08-00005-00]
- National Institute of Diabetes and Digestive and Kidney Diseases/National Institutes of Health [R01DK112254]
- [R01 AI145296]
- [R01 AI127463]
- [AI138718 01]
Ask authors/readers for more resources
Bacterial vaginosis is a condition that increases the risk of acquiring sexually transmitted infections and other reproductive tract complications. Antibiotic treatment often fails to restore the microbiome to a healthy state. This study aimed to identify the community signatures associated with treatment failure. The results showed that diverse microbiota communities were linked to enhanced resilience of bacterial vaginosis to standard metronidazole treatment. Soluble immune factors improved temporarily following a shift to a Lactobacillus-dominant microbiome, but these changes did not prevent recurrence.
BACKGROUND: Bacterial vaginosis-a condition defined by a shift from Lactobacillus dominance to a polymicrobial, anaerobic bacterial community-increases the risk of acquiring sexually transmitted infections and other complications of the female reproductive tract. Antibiotic treatment frequently fails to return the microbiome to an optimal Lactobacillus-dominated state. No criteria currently exist to identify the patients likely to experience treatment failure. OBJECTIVE: We sought to identify the pretreatment community signatures associated with treatment failure through 16S ribosomal RNA gene analysis. STUDY DESIGN: Twenty-eight women who were enrolled in an oral metronidazole treatment trial of bacterial vaginosis were studied. Cervicovaginal lavage samples were collected before metronidazole treatment and at 7 and 30 days posttreatment. Cervicovaginal lavage DNA was amplified and sequenced using a paired-end, V4 region 2x150 MiSeq run. RESULTS: Of the 28 women, 25% failed to clear bacterial vaginosis; 35.7% demonstrated a transient clearance, shifting to community-type 2 (Lactobacillus iners dominant) at visit 2 only; 7.1% demonstrated a delayed clearance, reaching community-type 2 at the final visit only; and 32.1% of patients experienced sustained bacterial vaginosis clearance. Examination of the community composition and structure demonstrated that both the richness and the evenness were significantly lower for the women who experienced sustained clearance, whereas the women who failed to clear bacterial vaginosis possessed the highest median levels of richness, evenness, and diversity pretreatment. Soluble immune factors in the lower reproductive tract improved significantly following a shift from community-type 4 to a Lactobacillus-dominant microbiome, with the samples categorized as community-type 2 possessing significantly higher levels of secretory leukocyte protease inhibitor, growth-regulated alpha protein, and macrophage inflammatory protein-3 and significantly lower levels of intercellular adhesion molecule-1. Although the shifts to Lactobacillus dominance improved the markers of mucosal tissue health, these gains were only temporary among the women who experienced recurrence. CONCLUSION: Assemblies of highly diverse microbiota are associated with the enhanced resilience of bacterial vaginosis to standard metronidazole treatment. These communities may be foundational to treatment resistance or simply an indication of a well-established community made possible by canonical biofilm-forming taxa. Future studies must target the transcriptional activity of these communities under the pressure of antibiotic treatment to resolve the mechanisms of their resistance.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available